Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Completed 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Lung Neoplasms 1

Interventions

pembrolizumab 66Cyclophosphamide 44Cisplatin 43Nivolumab 36Paclitaxel 32Carboplatin 31Radiotherapy 29Gemcitabine 28Docetaxel 25Dexamethasone 22atezolizumab 21Doxorubicin 19Bevacizumab 19Magnetic Resonance Spectroscopy 17fludarabine 16Vincristine 16Lenalidomide 16Etoposide 16Radiosurgery 15Letrozole 15Ipilimumab 15Fluorouracil 15Blood Specimen Collection 15palbociclib 14Rituximab 14Radiation 14Leucovorin 14Cytarabine 14Surveys and Questionnaires 13Specimen Handling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Patient Education as Topic × 90 days × Clear all
NCT06225414 2026-03-30

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

University of California, Irvine

Phase NA Completed
60 enrolled
Thoracic

Lung Neoplasms

NCT04705038 2026-03-27

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

University of Chicago

Phase NA Completed
101 enrolled
Genitourinary

Prostatic Neoplasms

NCT05046171 2026-03-24

Decreasing Polypharmacy in Older Adults With Curable Cancers Trial

University of Rochester

Phase 1/2 Completed
51 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡